Sana Biotechnology, Inc.
SANA
$1.76
-$0.01-0.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 22.95% | -14.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.71% | 16.66% | |||
| Operating Income | 15.71% | -16.66% | |||
| Income Before Tax | 18.11% | -19.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.11% | -19.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.11% | -19.15% | |||
| EBIT | 15.71% | -16.66% | |||
| EBITDA | 16.37% | -17.65% | |||
| EPS Basic | 18.39% | -18.65% | |||
| Normalized Basic EPS | 23.97% | -10.76% | |||
| EPS Diluted | 18.31% | -18.65% | |||
| Normalized Diluted EPS | 23.97% | -10.76% | |||
| Average Basic Shares Outstanding | 0.38% | 0.41% | |||
| Average Diluted Shares Outstanding | 0.38% | 0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||